NCT00731523View on ClinicalTrials.gov

Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2008

Conditions
Renal Insufficiency
Interventions
DRUG

fingolimod (FTY720)

Trial Locations (1)

Unknown

Novartis Investigator Site, Moscow

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY